FR2747691B1 - NUCLEIC ACIDS AND PROTEINS USEFUL AS ANTI-CANCER AND ANTIVIRAL AGENT - Google Patents
NUCLEIC ACIDS AND PROTEINS USEFUL AS ANTI-CANCER AND ANTIVIRAL AGENTInfo
- Publication number
- FR2747691B1 FR2747691B1 FR9604853A FR9604853A FR2747691B1 FR 2747691 B1 FR2747691 B1 FR 2747691B1 FR 9604853 A FR9604853 A FR 9604853A FR 9604853 A FR9604853 A FR 9604853A FR 2747691 B1 FR2747691 B1 FR 2747691B1
- Authority
- FR
- France
- Prior art keywords
- cancer
- nucleic acids
- antiviral agent
- proteins useful
- proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/023—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a poxvirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/028—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a herpesvirus
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9604853A FR2747691B1 (en) | 1996-04-18 | 1996-04-18 | NUCLEIC ACIDS AND PROTEINS USEFUL AS ANTI-CANCER AND ANTIVIRAL AGENT |
EP96943177A EP0868512B9 (en) | 1995-12-20 | 1996-12-20 | Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
JP9522549A JP2000502893A (en) | 1995-12-20 | 1996-12-20 | Nucleotide sequences, proteins, drugs and diagnostics to treat cancer |
AT96943177T ATE307886T1 (en) | 1995-12-20 | 1996-12-20 | NUCLEOTIDE SEQUENCES, PROTEINS, MEDICATIONS AND DIAGNOSTIC AGENTS FOR USE IN CANCER TREATMENT |
CA002240449A CA2240449A1 (en) | 1995-12-20 | 1996-12-20 | Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
PCT/FR1996/002061 WO1997022695A2 (en) | 1995-12-20 | 1996-12-20 | Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
DE69635349T DE69635349T2 (en) | 1995-12-20 | 1996-12-20 | NUCLEOTIDE SEQUENCES, PROTEINS, MEDICAMENTS AND DIAGNOSIS AGENTS FOR THE USE OF CANCER TREATMENT |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9604853A FR2747691B1 (en) | 1996-04-18 | 1996-04-18 | NUCLEIC ACIDS AND PROTEINS USEFUL AS ANTI-CANCER AND ANTIVIRAL AGENT |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2747691A1 FR2747691A1 (en) | 1997-10-24 |
FR2747691B1 true FR2747691B1 (en) | 1998-08-28 |
Family
ID=9491329
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR9604853A Expired - Fee Related FR2747691B1 (en) | 1995-12-20 | 1996-04-18 | NUCLEIC ACIDS AND PROTEINS USEFUL AS ANTI-CANCER AND ANTIVIRAL AGENT |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2747691B1 (en) |
-
1996
- 1996-04-18 FR FR9604853A patent/FR2747691B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
FR2747691A1 (en) | 1997-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2007020I1 (en) | CERTAIN 5-ALKYL-2-ARYLAMINOPHENYLACETIC ACIDS AND DERIVATIVES | |
LU91029I2 (en) | Interferon conjugates | |
FI970656A0 (en) | Weight regulators, corresponding nucleic acids and proteins and their diagnostic and therapeutic uses | |
HK1061841A1 (en) | Cyclic amino acids and derivatives thereof useful as pharmaceutical agents | |
MA24307A1 (en) | DERIVATIVES OF ARYLSULFONYLAMINO-HYDROXAMIC ACIDS. | |
FI953837A (en) | Synthetic activating amino acids | |
ATE266383T1 (en) | DERMATOLOGICAL PREPARATIONS | |
DK0991658T3 (en) | Dolastatin 15 derivatives | |
FI952069A0 (en) | Low allergenic proteins | |
IT1291366B1 (en) | ANTIVIRAL PHARMACEUTICAL COMPOSITION INCLUDING GLYCYRHIZIC ACID AND AT LEAST ONE PROTEIN WITH ANTIVIRAL ACTIVITY | |
FR2763953B1 (en) | 5'-DESOXY-CYTIDINE DERIVATIVES | |
FI951101A (en) | 5-Vinyl and 5-ethynylquinolone and naphthyridonecarboxylic acids | |
ITMI941469A0 (en) | PROTEINS WITH ANTI-CANCER ACTIVITY | |
IS4629A (en) | Linked viral nucleic acids | |
DE59603621D1 (en) | LEUKOINDIGO PREPARATIONS IN GRANULATE FORM | |
FR2747691B1 (en) | NUCLEIC ACIDS AND PROTEINS USEFUL AS ANTI-CANCER AND ANTIVIRAL AGENT | |
FI971085A0 (en) | New PKA-binding proteins and their uses | |
DE69524720D1 (en) | DERMATOLOGICAL PREPARATIONS | |
FR2759747B1 (en) | STAPLING CLIP | |
IT1293525B1 (en) | BIS-ACRIDINCARBOSSIAMIDI HAVING ANTI-CANCER ACTIVITY | |
FR2756564B1 (en) | QUINOLEINE-8-CARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION | |
FR2751970B1 (en) | 6,7,8,9-TETRAHYDRO-5H-IMIDAZO [1,2-A] AZEPINE-3-ACETIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION | |
ITFI920146A0 (en) | FUNCTIONAL PROTEINS AND THEIR USE FOR THE PREPARATION OF CONJUGATES | |
ATA114093A (en) | MARKED ALPHA AMINO ACIDS | |
ZA921892B (en) | Proteins and nucleic acids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TP | Transmission of property | ||
ST | Notification of lapse |
Effective date: 20081231 |